- By insider
Chairman and CEO of Invitae Corp (NVTA) Randal W Scott bought 66,666 shares of NVTA on 11/22/2016 at an average price of $6 a share. The total cost of this purchase was $399,996.
Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions. Invitae Corp has a market cap of $225.510 million; its shares were traded at around $6.95 with and P/S ratio of 11.41.
-
Warning! GuruFocus has detected 2 Warning Signs with NVTA. Click here to check it out.
-
The intrinsic value of NVTA
CEO Recent Trades:
-
Chairman and CEO, 10% Owner Randal W Scott bought 66,666 shares of NVTA stock on 11/22/2016 at the average price of $6. The price of the stock has increased by 15.83% since.
Directors and Officers Recent Trades:
-
Director Geoffrey Crouse bought 15,000 shares of NVTA stock on 11/18/2016 at the average price of $6.25. The price of the stock has increased by 11.2% since.
-
Director Eric Aguiar bought 10,000 shares of NVTA stock on 11/18/2016 at the average price of $6.28. The price of the stock has increased by 10.67% since.
-
10% Owner Bros. Advisors Lp Baker bought 733,333 shares of NVTA stock on 11/17/2016 at the average price of $6. The price of the stock has increased by 15.83% since.
For the complete insider trading history of NVTA, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Signs with NVTA. Click here to check it out.
-
The intrinsic value of NVTA